News Topic: Vor’s first-in-human clinical trial of VBP101
Timmerman Report – Vor Bio Shows CRISPR’d Stem Cell Transplants Take Hold in AML Patients, Enable ADCs (Subscription Required)
Fierce Biotech – Vor Bio’s dual stem cell, ADC treatment shows consistent engraftment with reduced toxicity, but response data absent
From Concept to Clinical Trial Results: A Conversation with Glen Raffel, MD, PhD, VP of Clinical Research & Development
As we continue to share results from our first clinical trial, VBP101, we checked in with our Vice President of Clinical Research & Development, Glen Raffel, MD, PhD, to find out what it’s like seeing this concept progress from an idea to a clinical trial where we are now seeing results in patients who have received this drug candidate. […]